News |
Investors
CONTACT US

Rafael Holdings

home Navigation
  • Leadership
    • Board of Directors
    • Executive Management
  • Rafael Pharmaceuticals
  • Rafael Pharmaceuticals
  • Real Estate Holdings
  • Lipomedix Pharmaceuticals
  • Leadership
    • Board of Directors
    • Executive Management
Investors

Investors

News

 
Mar 17, 2022
Click to open news item in new windowRafael Holdings Reports Second Quarter Fiscal 2022 Financial Results

Jan 21, 2022
Click to open news item in new windowWilliam "Bill" Conkling to assume the role of Chief Executive Officer as of February 1, 2022

Dec 15, 2021
Click to open news item in new windowRafael Holdings Reports First Quarter Fiscal 2022 Financial and Operating Results

Nov 22, 2021
Click to open news item in new windowRafael Holdings Realigns Leadership Team to Support Earlier Stage Pipeline Focus

Oct 28, 2021
Click to open news item in new windowRafael Holdings Provides Update on Rafael Pharmaceuticals' Two Phase 3 Trials of CPI-613® (Devimistat), AVENGER 500 in Metastatic Pancreatic Cancer and ARMADA 2000 in Relapsed or Refractory Acute Myeloid Leukemia

Oct 18, 2021
Click to open news item in new windowRafael Holdings Announces Inducement Grant Under NYSE Rule 303A.08

Oct 18, 2021
Click to open news item in new windowRafael Holdings Reports Fourth Quarter and Full Year Fiscal 2021 Financial and Operating Results and Provides Business Update

Oct 06, 2021
Click to open news item in new windowRafael Holdings Appoints Mimi Huizinga, MD, MPH as Chief Development and Medical Officer

Sep 24, 2021
Click to open news item in new windowRafael Holdings Continues to Expand its Management Team with a Highly Experienced Global Biopharmaceutical Executive to Build a Fully Integrated Cancer Metabolism Therapeutics Company and Announces Inducement Grant Under NYSE Rule 303A.08

Sep 17, 2021
Click to open news item in new windowRafael Holdings Announces Inducement Grant Under NYSE Rule 303A.08

   1    2   3   4   5   6 
 <<   <   >   >> 
  • Real Estate Holdings
  • Rafael Pharmaceuticals
  • Lipomedix Pharmaceuticals
  • Leadership
  • Press Releases
  • News Coverage
  • Investors
  • Contact Us
  • Privacy Policy
  • Disclaimer

Copyright © Rafael Holdings, Inc. All rights reserved


Privacy
Resize Viewer - Reduce Resize Viewer - Expand Close window